MedTrace Logo

Women and Risk of Type 2 Diabetes

NCT03870724 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 383

Last updated 2022-11-03

No results posted yet for this study

Summary

This is a follow-up survey of women, 10-12 years after they were included in the population-based Stork Groruddalen study of pregnant women, primarily set up to study gestational diabetes and related health issues in pregnancy in a multiethnic population. The investigators will now update the information about the health status of these women to study the development of risk factors for type 2 diabetes and cardiovascular diseases.

Conditions

Sponsors & Collaborators

  • Norwegian Diabetes Association

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Anne Karen Jenum · University of Oslo

Eligibility

Min Age
27 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-27
Primary Completion
2022-03-30
Completion
2022-03-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870724 on ClinicalTrials.gov